Location · Louisville, KY
Clinical trials in Louisville, KY
153 recruiting studies have a site in the Louisville area, and 31 of them accept healthy volunteers. The area includes Jeffersontown, Shepherdsville, New Albany, IN, Jeffersonville, IN and nearby cities.
153 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
This Study Will Evaluate the Effectiveness of NTX-001, a Surgical Nerve Repair Product When Used in People With Upper Extremity Nerve Lacerations.
Neuraptive Therapeutics Inc.
- Location
- Orlando, FL + 22 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Spyre Therapeutics, Inc.
- Location
- Canoga Park, CA + 25 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Kymera Therapeutics, Inc.
- Location
- Lancaster, CA + 30 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Boston Scientific Corporation
- Location
- Huntsville, AL + 39 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Amgen
- Location
- Anniston, AL + 69 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 3
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
AstraZeneca
- Location
- Mobile, AL + 30 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
ELEVATE-HFpEF Clinical Study
Medtronic Cardiac Rhythm and Heart Failure
- Location
- Phoenix, AZ + 25 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Supernus Pharmaceuticals, Inc.
- Location
- Phoenix, AZ + 36 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 2
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Akebia Therapeutics
- Location
- Chula Vista, CA + 28 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Shockwave Medical, Inc.
- Location
- Phoenix, AZ + 66 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Amgen
- Location
- Scottsdale, AZ + 57 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
- Location
- Huntsville, AL + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Dothan, AL + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 2
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 22 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Crystalys Therapeutics
- Location
- Birmingham, AL + 81 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Crystalys Therapeutics
- Location
- Birmingham, AL + 82 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Takeda
- Location
- Murrieta, CA + 23 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
AstraZeneca
- Location
- Bakersfield, CA + 21 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2/Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
- Location
- Chandler, AZ + 53 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Enveda Therapeutics
- Location
- Birmingham, AL + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
AstraZeneca
- Location
- La Palma, CA + 14 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
AstraZeneca
- Location
- Surprise, AZ + 9 other US sites
- Eligibility basics
- Ages 18–99
- RecruitingPhase 2/Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
CSL Behring
- Location
- Decatur, AL + 147 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Takeda
- Location
- Dothan, AL + 36 other US sites
- Eligibility basics
- Ages 18–65